Clinical Trial Update: Multicountry, Multicenter Post-Marketing Observational Study of Clinical, Biological and Virological Outcomes, Compliance and Tolerability of Kaletra® in Routine Clinical Use

View source ↗

Summary

A multicountry, multicenter post-marketing observational study evaluating Kaletra (lopinavir/ritonavir) in routine HIV-1 care, focusing on clinical, biological,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Kaletra (lopinavir)

Snippet

Sponsor: Abbott | Conditions: HIV-1 Patients | Status: COMPLETED | Results posted: 2011-09-12